Acne Scars study: Juläine
Official title Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars
ClinicalTrials.gov ID: NCT07058883
What this study is testing
- What it's testing
- The study will see if Juläine is safe and can improve the look of acne scars compared with a saline placebo.
- Who it's for
- People with atrophic acne scars on their face who can attend clinic visits in Poland.
- What's involved
- Participants will receive three injections of either Juläine or saline over two months, then be followed for 12 months with skin checks and imaging.
- Time commitment
- The study lasts about 14 months, with three injection visits in the first two months and regular follow‑up visits for a year afterward.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Presence of moderate to severe atrophic facial acne scars
- Immune-competent adult
- Willing and able to comply with study procedures and follow-up visits
- Signed informed consent obtained
You likely can't join if
- Active acne, infection, or chronic skin disease in the treatment area
- Known allergy or hypersensitivity to any component of Juläine
- History of keloid formation or hypertrophic scarring
- Current anticoagulant therapy or bleeding disorder
- Pregnant or breastfeeding
- Previous aesthetic treatment in the same area within the past 6 months
See the full eligibility criteria
- Age 18 years or older
- Presence of moderate to severe atrophic facial acne scars
- Immune-competent adult
- Willing and able to comply with study procedures and follow-up visits
- Signed informed consent obtained
- Active acne, infection, or chronic skin disease in the treatment area
- Known allergy or hypersensitivity to any component of Juläine
- History of keloid formation or hypertrophic scarring
- Current anticoagulant therapy or bleeding disorder
- Pregnant or breastfeeding
- Previous aesthetic treatment in the same area within the past 6 months
- Participation in another treatment clinical trial within 30 days before enrollment
The study team makes the final eligibility decision.
Where it is enrolling
- Gdansk, Poland
- Gdynia, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Gdansk, Poland; Gdynia, Poland. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.